TONIC HEMP, LLC – Trademark Portfolio
Entity Type: 16
TONIC HEMP, LLC owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as PTS, PTS FARMS, and PROGRESSIVE TREATMENT SOLUTIONS. Of these, 3 are registered and 4 are pending. The portfolio spans 6 Nice Classification classes, led by Class 25 (Clothing) and Class 5 (Pharmaceuticals). Headquartered in PALATINE, IL.
STE 112
4801 EMERSON AVE
PALATINE, IL 60067
Showing of trademarks Trademarks
Trademark Classifications
TONIC HEMP, LLC's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does TONIC HEMP, LLC have?
TONIC HEMP, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending.
What trademark classes does TONIC HEMP, LLC file in?
TONIC HEMP, LLC files trademarks across 6 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 34 (Smokers Articles). Class 25 covers clothing, footwear, headgear.
What are TONIC HEMP, LLC's most well-known trademarks?
TONIC HEMP, LLC's registered trademark portfolio includes well-known marks such as PTS, PTS FARMS, and PROGRESSIVE TREATMENT SOLUTIONS. These are among 3 currently registered trademarks in the portfolio.
What is TONIC HEMP, LLC's trademark registration success rate?
TONIC HEMP, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.